Skip to main content

Stochastic SIRC epidemic model with time-delay for COVID-19


Environmental factors, such as humidity, precipitation, and temperature, have significant impacts on the spread of the new strain coronavirus COVID-19 to humans. In this paper, we use a stochastic epidemic SIRC model, with cross-immune class and time-delay in transmission terms, for the spread of COVID-19. We analyze the model and prove the existence and uniqueness of positive global solution. We deduce the basic reproduction number \({\mathcal{R}}_{0}^{s}\) for the stochastic model which is smaller than \({\mathcal{R}}_{0}\) of the corresponding deterministic model. Sufficient conditions that guarantee the existence of a unique ergodic stationary distribution, using the stochastic Lyapunov function, and conditions for the extinction of the disease are obtained. Our findings show that white noise plays an important part in controlling the spread of the disease; When the white noise is relatively large, the infectious diseases will become extinct; Re-infection and periodic outbreaks can occur due to the existence of feedback time-delay (or memory) in the transmission terms.


The ongoing pandemic coronavirus disease (COVID-19) has become a worldwide emergency. This infectious disease is spreading fast, endangering a large number of people’s health, and thus immediate actions and intensive studies are needed to control the disease in communities [1]. COVID-19 is the seventh member of the coronavirus (CoV) family, such as MERS-CoV and SARS-CoV [2]. Although SARS-CoV was more deadly, it was much less infectious than COVID-19. There have been no outbreaks of SARS anywhere in the world since 2003. The symptoms of the COVID-19 infection include cough, fever, tiredness, diarrhea, and shortness of breath. Mostly in severe cases, COVID-19 causes pneumonia and death [3]. The primary studies show that the incubation period of COVID-19 is between 3–14 days or longer [4]. Additionally, the average of basic reproduction number \({\mathcal{R}}_{0}\) for COVID-19 is about 2–2.8. The disease may still be infectious in the latent infection period. Studies to date suggest that the virus is very serious and spreads fast from person to person through close contact and respiratory droplets rather than through the air [4]. Table 1 shows the incubation period of several common infectious diseases.

Table 1 Incubation period of several common infectious diseases

Mathematical modeling of the infectious diseases has an important role in the epidemiological aspect of disease control [58]. Several epidemic models, with various characteristics, have been described and investigated in the literature. Most of these models are based on susceptible–infected–removed (SIR) model. Casagrandi et al. [9] introduced a SIRC model to describe the dynamical behaviors of influenza A by inserting a new compartment, namely cross-immunity (C) componentFootnote 1 of people who have been recovered after being infected by different strains of the same viral subtype in previous years. The component C describes an intermediate state between the susceptible S and the recovered R. Rihan et al. [10] investigated the qualitative behaviors of a fractional-order SIRC model for salmonella bacterial infection. Recently in [11], the authors provided a deterministic SEIR epidemic model of fractional order to describe the dynamics of COVID-19. In other descriptions, quarantine state (Q) may be included in the presence of subjects, such as SIRQ models [12].

In fact, stochastic perturbation factors, such as precipitation, absolute humidity, and temperature, have a significant impact on the infection force of all types of virus diseases to humans. Taking this into consideration enables us to present randomness into deterministic biological models to expose the environmental variability effect, whether it is environmental fluctuations in parameters or random noise in the differential systems [1317]. Moreover, stochastic models give an extra degree of freedom and realism in comparison with their corresponding deterministic models. Stochastic population dynamics perturbed by white noise (or Brownian motion) has been studied extensively by many authors [1820]. It has been investigated in [21] that an environmental Brownian noise can suppress explosions in population dynamics. Yuan et al. [22] discussed the results of stochastic viral infection, immune response dynamics and analyzed the human immuno-deficiency virus infection. In [23], the author investigated the existence results of ergodic distribution for stochastic hepatitis B virus model based on Lyapunov function. In [24], the authors explored the dynamics of SIR epidemic model with environmental fluctuations. Additionally, they calculated a threshold parameter to demonstrate the persistence and extinction of the disease. Recently, Lakshmi et al. [25] identified some environmental factors such as geographic location of the countries, the upcoming climate, atmospheric temperature, humidity, sociobiological factors, etc., that influence the global spread of COVID-19.

Up-to-date studies have reported that there are many COVID-19 carriers who are not suffering from the disease. This may be due to cross-immunity of other virus survivors, people who have been recovered from the virus, such as other stains of coronavirus, H1N1, or influenza A. It has been reported in [2] that “T-cells that target SARS-CoV2, the virus that causes COVID-19, in the blood of people who had recovered from a coronavirus infection.” Accordingly, in the present paper, we investigate an SIRC epidemic model of cross-immune class for the dynamics of COVID-19 infection among groups. We include time-delay in the transmission terms to represent the incubation period of the virus (the time between infection and symptom onset). We also incorporate white noise type of perturbations to reveal the effect of environmental fluctuations and variability in parameters. Based on the existing literature, this is the first work dealing with the persistence and extinction of a stochastic epidemic model for the COVID-19 infection. We investigate the impact of small and large values of white noise in the persistence and extinction of the disease. We also derive the existence results of stationary distribution and extinction of the disease using a novel combination of stochastic Lyapunov functional. This paper is presented as follows: We provide a stochastic SIRC model with time-delay in Sect. 2. In Sect. 3, we study the existence and uniqueness of a global positive solution for the stochastic delayed SIRC model. In Sect. 4, a stationary distribution and extinction analysis of the underlying model are investigated. Some virtual numerical examples are presented in Sect. 5. Finally, concluding remarks are given in Sect. 6.

Stochastic SIRC epidemic model

For the spread of the COVID-19 disease in humans, we classify the population into four categories: \(S(t)\), \(I(t)\), \(R(t)\), and \(C(t)\) are the proportion of susceptible, infected, recovered, and cross-immune ones at time t, respectively. Let \(N(t)=S(t)+I(t)+R(t)+C(t)\) be the total population. At this stage, we believe that a SIRC model efficiently describes the mechanism for the spreading of the COVID-19 virus. The classical SIRC model [9, 32] takes the form

$$\begin{aligned} \begin{gathered} \dot{S}(t)= \eta \bigl(1-S(t) \bigr)-\xi S(t)I{(t-\tau })+\beta C(t), \\ \dot{I}(t)=\xi S(t)I(t-\tau )+ \sigma \xi C(t)I(t)-(\eta +\alpha )I(t), \\ \dot{R}(t)= (1- \sigma )\xi C(t)I(t)+\alpha I(t)-(\eta +\gamma )R(t), \\ \dot{C}(t)= \gamma R(t)-\xi C(t)I(t)-(\eta +\beta )C(t). \end{gathered} \end{aligned}$$

We incorporate a discrete time-delay τ into the SIRC model to represent the incubation period which is about 3–14 days [4]. All the parameters appearing in the model are nonnegative, see Table 2. In the absence of cross-immunity i.e. \((1-\sigma =0)\), the SIRC model curtails to the SIRS model since the two individuals S and C become immunologically indistinguishable. Figure 1 shows the scheme of SIRC model.

Figure 1

Scheme of SIRC model (1)

Table 2 Description of the model parameters

Time-delay \(\tau >0\) is incorporated in the transmission terms to represent the incubation period of the viral infection, the time between infection and symptom onset. The current studies show that the average/median of incubation period of early confirmed cases of COVID-19 is about 5.5 days, which is similar to SARS-CoV. Presence of time-delay in the model may cause periodic solutions many times for different time-delay values τ [33].

Model (1) has a disease-free equilibrium \({\mathcal{E}}_{0}=[1,0,0,0]\) and an endemic equilibrium \({\mathcal{E}}_{+}=[S^{*},I^{*},R^{*},C^{*}]\), where

$$\begin{aligned}& S^{*}= \frac{\eta +\alpha }{\xi }- \frac{\beta \gamma \alpha I^{*}}{[(\eta +\gamma )-(1-\sigma )\gamma ]\xi I^{*}+(\eta +\beta )(\eta +\gamma )}, \\& R^{*}= \frac{\alpha I^{*}(\xi I^{*}+\eta +\beta )}{[(\eta +\gamma )-(1-\sigma )\gamma ]\xi I^{*}+(\eta +\beta )(\eta +\gamma )}, \\& C^{*}= \frac{\gamma \alpha I^{*}}{[(\eta +\gamma )-(1-\sigma )\gamma ]\xi I^{*}+(\eta +\beta )(\eta +\gamma )}, \end{aligned}$$

and \(I^{*}\) is a root of quadratic equation \(p I^{2}+q I+r=0\), where

$$\begin{aligned} \begin{gathered} p= \eta \xi (\eta +\alpha +\sigma \gamma ), \\ q= \eta \xi \bigl[ \alpha (2\eta +\gamma +\beta )+(\eta +\beta ) ( \eta +\gamma ) +(\eta +\sigma \gamma ) (\eta -\xi ) \bigr], \\ r= \eta (\eta +\beta ) (\eta +\gamma ) (\eta +\alpha ) (1-{ \mathcal{R}}_{0}). \end{gathered} \end{aligned}$$

Here \({\mathcal{R}}_{0}=\frac{\xi }{\eta +\alpha }\) is known as the basic reproduction number of the deterministic model.

In fact, there is an increasing indication that superior consistency with some phenomena can be contributed if the effects of environmental noises in the system are taken into account [34]. Epidemic model (1) assumes that the observed dynamics are driven exclusively by internal deterministic cases. Ignoring environmental variability in the modeling may affect the dynamics of the model and transmission of the disease. Accordingly, there is a need to extend the deterministic systems described by differential equations into stochastic differential equations (SDEs), where related parameters are modeled as suitable stochastic processes, added to the driving system equations.

From the mathematical and biological point of view, there are some assumptions to incorporate stochastic perturbations into the epidemiological model, such as Markov chain process, parameter perturbations, white noise type, etc. Here, we incorporate white noise type perturbation into model (1), which is proportional to the S, I, R, C classes, so that

$$\begin{aligned} \begin{aligned} &d{S}(t)= \bigl[\eta \bigl(1-S(t)\bigr)-\xi S(t)I({t-\tau })+\beta C(t)\bigr]\,dt+ \nu _{1} S(t) \,dW_{1}(t), \\ &d{I}(t)=\bigl[\xi S(t)I({t-\tau })+ \sigma \xi C(t)I(t)-(\eta +\alpha )I(t) \bigr]\,dt+ \nu _{2} I(t) \,dW_{2}(t) , \\ &d{R}(t)= \bigl[(1- \sigma )\xi C(t)I(t)+\alpha I(t)-(\eta +\gamma )R(t)\bigr] \,dt +\nu _{3} R(t) \,dW_{3}(t) , \\ &d{C}(t)= \bigl[\gamma R(t)-\xi C(t)I(t)-(\eta +\beta )C(t)\bigr]\,dt +\nu _{4} C(t) \,dW_{4}(t), \end{aligned} \end{aligned}$$

where \(W_{1}(t)\), \(W_{2}(t)\), \(W_{3}(t)\), and \(W_{4}(t)\) stand for the independent Brownian motions. \(\nu _{1}^{2}\), \(\nu _{2}^{2}\), \(\nu _{3}^{2}\), and \(\nu _{4}^{2}\) represent the intensity of the environmental white noises, \(\nu _{i}>0\) (\(i=1,2,3,4\)) subject to the following initial conditions:

$$ \begin{aligned} &S(\theta )=\phi _{1}(\theta ),\quad\quad I(\theta )=\phi _{2}( \theta ), \\ &R(\theta )=\phi _{3}(\theta ),\quad\quad C(\theta )=\phi _{4}(\theta ), \quad \theta \in [-\tau ,0], \\ &\phi _{i}(\theta )\in {\mathcal{C}},\quad i=1,2,3,4, \end{aligned} $$

such that \({\mathcal{C}}\) is a family of Lebesgue integrable functions from \([-\tau ,0]\) into \(\mathbb{R}_{+}^{4}\).

Existence and uniqueness of the positive solution

To investigate the dynamical characteristics of SDDEs (2), the first consideration is to verify if system (2) has a unique global positive solution. As the coefficients of system (2) satisfy the local Lipschitz condition together with the linear growth condition [35, 36], there exists a unique local solution. Now, we need to prove that the solution is positive and global using the Lyapunov analysis method [36].

Theorem 1

System (2) has a unique positive solution \((S(t),I(t),R(t),C(t))\)on \(t\geq -\tau \), and the solution will remain in \({\mathbb{R}}_{+}^{4}\)for the given initial condition (3) with probability one.

Proof 1

For any initial value (3), as the coefficients of system (2) satisfy the local Lipschitz condition, so system (2) has a unique local solution \((S(t), I(t), R(t), C(t))\) on \(t \in [-\tau , \tau _{e})\) a.s., where \(\tau _{e}\) represents the explosion time [36].

Our aim is to show that this solution is global i.e. \(\tau _{e} = \infty \) a.s. Assume \(n_{0} \geq 1\) to be sufficiently large such that \(S(\theta )\), \(I(\theta )\), \(R(\theta )\), and \(C(\theta )\) (\(\theta \in [-\tau ,0]\)) are lying in the interval \([\frac{1}{n_{0}}, n_{0} ]\). For each \(n \geq n_{0}\), \(n \in \mathbb{N}\), define the stopping time

$$ \tau _{n}= \inf \biggl\{ t \in [-\tau , \tau _{e}): \min \bigl\{ S(t),I(t),R(t),C(t) \bigr\} \leq \frac{1}{n} \text{ or }\max \bigl\{ S(t),I(t),R(t),C(t)\bigr\} \geq n \biggr\} , $$

we fix \(\inf \phi = \infty \) (ϕ is the empty set). Apparently, \(\tau _{n}\) is increasing as \(n \rightarrow \infty \). Assume \(\tau _{\infty }= \lim_{n \rightarrow \infty } \tau _{n}\), then \(\tau _{\infty } \leq \tau _{e}\) a.s. Therefore, we need to show that \(\tau _{\infty }=\infty \) a.s., then \(\tau _{e}=\infty \) a.s. and \((S(t),I(t),R(t),C(t))\in \mathbb{R}_{+}^{4}\) a.s. for all \(t\geq -\tau \). If it is erroneous, there is a pair \(\epsilon \in (0, 1)\) and \(\widetilde{T}>0\) such that \(P\{\tau _{\infty } \leq \widetilde{T} \}> \epsilon \). Then there is an integer \(n_{1} \geq n_{0}\) such that

$$ P\{\tau _{n} \leq \widetilde{T} \} \geq \epsilon ,\quad \forall n \geq n_{1}.$$

We define a \({\mathcal{C}}^{2}\)-function \(\mathcal{V}: \mathbb{R}^{4}_{+} \rightarrow \mathbb{R}_{+}\) as follows:

$$ \begin{aligned} \mathcal{V}(S,I,R,C)&=\biggl(S-\kappa -\kappa \frac{ \ln S}{\kappa }\biggr)+ (I-1- \ln I) \\ &\quad{}+ (R-1-\ln R)+(C-1-\ln C)+ \int _{t}^{t+\tau } \kappa \xi I(s-\tau )\,ds, \end{aligned} $$

where \(\kappa >0\) is a constant to be determined. By Ito’s formula, we can obtain

$$\begin{aligned} \begin{aligned} d\mathcal{V}= {}&\mathcal{L}\mathcal{V} \,dt+\nu _{1}(S-\kappa ) \,dW_{1} (t) +\nu _{2}(I-1) \,dW_{2} (t)+\nu _{3}(R-1) \,dW_{3} (t)\\&{}+\nu _{4}(C-1) \,dW_{4} (t), \end{aligned} \end{aligned}$$


$$\begin{aligned} \mathcal{L} \mathcal{V}&= \biggl(1-\frac{\kappa }{S}\biggr) \bigl(\eta -\eta S- \xi S I(t- \tau ) + \beta C\bigr)+\biggl(1-\frac{1}{I}\biggr) \bigl(\xi SI(t-\tau )+\sigma \xi CI-( \eta +\alpha )I\bigr) \\ & \quad {} + \biggl(1-\frac{1}{R}\biggr) (\xi CI - \sigma \xi CI+ \alpha I-\eta R - \gamma R)+\biggl(1-\frac{1}{C}\biggr) \bigl(\gamma R-\xi CI \\ & \quad {} -(\eta +\beta )C\bigr)+ \frac{ \kappa \nu _{1}^{2}+\nu _{2}^{2}+\nu _{3}^{2}+\nu _{4}^{2} }{2}+ \kappa \xi I(t)-\kappa \xi I(t-\tau ) \\ &\leq 4\eta +\kappa \eta +\alpha +\beta +\gamma -\eta C-\eta R+\bigl(\xi (1+ \kappa )-\alpha \bigr)I-\eta I-\eta S+ \frac{\kappa \nu _{1}^{2}+\nu _{2}^{2}+\nu _{3}^{2}+\nu _{4}^{2} }{ 2}. \end{aligned}$$

Let \(\kappa =\frac{\alpha -\xi }{\xi }\), then we have

$$ \begin{aligned} \mathcal{L}\mathcal{V}&\leq 4\eta +\kappa \eta +\alpha + \beta +\gamma + \frac{\kappa \nu _{1}^{2}+\nu _{2}^{2}+\nu _{3}^{2}+\nu _{4}^{2} }{2} \leq \mathcal{M}, \end{aligned} $$

where \(\mathcal{M}>0\) is a constant which is independent of \(S(t)\), \(I(t)\), \(R(t)\), and \(C(t)\). Therefore,

$$\begin{aligned} \begin{aligned}d\mathcal{V}(S,I,R,C)&\leq \mathcal{M}\,dt+\nu _{1}(S- \kappa ) \,dW_{1} (t)+\nu _{2}(I-1) \,dW_{2} (t) \\ &\quad{}+ \nu _{3}(R-1) \,dW_{3} (t)+\nu _{4}(C-1) \,dW_{4} (t). \end{aligned} \end{aligned}$$

Integrating (6) from 0 to \(\tau _{n}\wedge \widetilde{T}=\min \{\tau _{n},\widetilde{T}\}\) and then taking the expectation E on both sides, we have

$$ E\mathcal{V}\bigl(S(\tau _{n}\wedge \widetilde{T}),I( \tau _{n}\wedge \widetilde{T}),R(\tau _{n}\wedge \widetilde{T}),C(\tau _{n}\wedge \widetilde{T})\bigr)\leq E\mathcal{V} \bigl(S(0),I(0),R(0),C(0)\bigr)+\mathcal{M} \widetilde{T}. $$

Let \(\Omega _{n}=\{\tau _{n}\leq \widetilde{T}\}\), for \(n\geq n_{1}\) and in view of (4), we obtain \(P(\Omega _{n})\geq \epsilon \) such that, for every \(\omega \in \Omega _{n}\), there is at least one of \(S(\tau _{n},\omega )\), \(I(\tau _{n},\omega )\), \(R(\tau _{n},\omega )\), or \(C(\tau _{n},\omega )\) equaling either n or \(\frac{1}{n}\), and then we obtain

$$ \mathcal{V}\bigl(S(\tau _{n}\wedge \widetilde{T}),I(\tau _{n}\wedge \widetilde{T}),R(\tau _{n}\wedge \widetilde{T}),C(\tau _{n}\wedge \widetilde{T})\bigr)\geq (n-1-\ln n) \wedge \biggl(\frac{1}{n}-1-\ln \frac{1}{n}\biggr). $$

According to (7), we get

$$\begin{aligned} \begin{aligned} E\mathcal{V}\bigl(S(0),I(0),R(0),C(0)\bigr)+ \mathcal{M} \widetilde{T}&\geq E\bigl[1_{\Omega _{n}(\omega )}\mathcal{V}\bigl(S(\tau _{n}, \omega ),I(\tau _{n},\omega ),R(\tau _{n}, \omega )\bigr),C(\tau _{n}, \omega )\bigr] \\ &\geq \epsilon (n-1-\ln n)\wedge \biggl(\frac{1}{n}-1-\ln \frac{1}{n}\biggr), \end{aligned} \end{aligned}$$

where \(1_{\Omega _{n}}\) represents the indicator function of \(\Omega _{n}\). Letting \(n\rightarrow \infty \) yields

$$ \infty >E\mathcal{V}\bigl(S(0),I(0),R(0),C(0)\bigr)+\mathcal{M}\widetilde{T}= \infty , $$

which leads to a contradiction. It can be concluded that \(\tau _{\infty }=\infty \) a.s., which proves the theorem.

Existence of ergodic stationary distribution

Herein, we construct a suitable stochastic Lyapunov function to study the existence of a unique ergodic stationary distribution of the positive solutions to system (2). First, let us assume that \(X(t)\) is a regular time-homogenous Markov process in \(\mathbb{R}^{d}\) illustrated by the SDDE

$$ dX(t)=f\bigl(X(t),X(t-\tau ),t\bigr)\,dt+\sum_{r=1}^{d} g_{r}\bigl(X(t),t\bigr)\,dB_{r}(t). $$

The diffusion matrix of the process \(X(t)\) is

$$ \Lambda (x)=\bigl(\lambda _{ij}(x)\bigr),\quad \lambda _{ij}(x)=\sum_{r=1}^{d}g_{r}^{i}(x)g_{r}^{j}(x). $$

Lemma 1


The Markov process \(X(t)\)has a unique ergodic stationary distribution \(\pi (\cdot )\)if there exists a bounded domain \({\mathcal{U}}\subset \mathbb{R}^{d}\)with regular boundary Γ, and

  1. (i):

    there is a positive number \({\mathcal{K}}\)so that \(\sum_{i,j=1}^{d} \lambda _{ij}(x)\xi _{i}\xi _{j}\geq {\mathcal{K}} \vert \xi \vert ^{2}\), \(x\in {\mathcal{U}}\), \(\xi \in \mathbb{R}^{d}\).

  2. (ii):

    there exists a nonnegative \({\mathcal{C}}^{2}\)-function so that \({\mathcal{L}}\widetilde{V}\)is negative for any \(\mathbb{R}^{d} \setminus {\mathcal{U}}\).

Define the reproduction number of the stochastic model as follows:

$$ \mathcal{R}_{0}^{s}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\eta }\hat{\alpha }\hat{\gamma } \hat{\beta }}, $$

where \(\hat{\eta }=\eta +\frac{\nu _{1}^{2}}{2}\), \(\hat{\alpha }=\eta +\alpha +\frac{\nu _{2}^{2}}{2}\), \(\hat{\gamma }=\eta +\gamma +\frac{\nu _{3}^{2}}{2}\), and \(\hat{\beta }=\eta +\beta +\frac{\nu _{4}^{2}}{2}\).

Theorem 2

Assume that \(\mathcal{R}_{0}^{s}>1\)and \(\eta - \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}>0\), then for value \((S(0), I(0), R(0), C(0))\in \mathbb{R}^{4}_{+}\), system (2) has a unique ergodic stationary distribution \(\pi (\cdot )\).

Proof 2

First, we need to validate conditions \((i)\) and \((\mathit{ii})\) of Lemma 1. To prove condition \((i)\), the diffusion matrix of model (2) is described as follows:

$$ \Lambda = \begin{pmatrix} \nu _{1}^{2} S^{2} & 0 & 0 & 0 \\ 0 & \nu _{2}^{2} I^{2} & 0 & 0 \\ 0 & 0 & \nu _{3}^{2} R^{2} & 0 \\ 0 & 0 & 0 & \nu _{4}^{2} C^{2} \end{pmatrix}. $$

Then the matrix Λ is positive definite for any compact subset of \(\mathbb{R}^{4}_{+}\), then condition \((i)\) of Lemma 1 is satisfied.

Next, we prove condition \((\mathit{ii})\). Define \({\mathcal{C}}^{2}\)-function \(\mathcal{V}: \mathbb{R}^{4}_{+} \rightarrow \mathbb{R}\) as follows:

$$\begin{aligned} \mathcal{V}(S, I, R, C)&=Q \biggl(- \ln S - c_{1} \ln I-c_{2} \ln R-c_{3} \ln C+\xi \int _{t}^{t+\tau }I(s-\tau )\,ds \biggr) \\ &\quad {} -\ln S+\xi \int _{t}^{t+\tau }I(s-\tau )\,ds-\ln R-\ln C+ \frac{1}{\rho +1}(S+I+R+C)^{\rho +1} \\ &=Q \mathcal{V}_{1}+\mathcal{V}_{2}+\mathcal{V}_{3}+ \mathcal{V}_{4}+ \mathcal{V}_{5}, \end{aligned}$$

where \(c_{1}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\alpha }^{2}\hat{\gamma }\hat{\beta }}\), \(c_{2}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\alpha }\hat{\gamma }^{2}\hat{\beta }}\), and \(c_{3}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\alpha }\hat{\gamma }\hat{\beta }^{2}}\). Note that \(\mathcal{V}(S, I, R, C)\) is not only continuous, but also tends to +∞ as \((S, I, R, C)\) approaches the boundary of \(\mathbb{R}_{+}^{4}\) and \(\Vert (S, I, R, C) \Vert \rightarrow \infty \). Therefore, \(\mathcal{V}\) must have a minimum point \((S(0), I(0), R(0), C(0))\) in the interior of \(\mathbb{R}_{+}^{4}\). We define a \({\mathcal{C}}^{2}\)-function \(\widetilde{V}:\mathbb{R}_{+}^{4} \rightarrow \mathbb{R}_{+}\) as follows:

$$ \begin{aligned} \widetilde{V}(S, I, R, C)&=Q \biggl(- \ln S - c_{1} \ln I-c_{2} \ln R-c_{3} \ln C+\xi \int _{t}^{t+\tau }I(s-\tau )\,ds \biggr) \\ &\quad {} -\ln S+\xi \int _{t}^{t+\tau }I(s-\tau )\,ds-\ln R-\ln C+ \frac{1}{\rho +1}(S+I+R+C)^{\rho +1} \\ &\quad {} -\mathcal{V}\bigl(S(0), I(0), R(0), C(0)\bigr) \\ &:=Q \mathcal{V}_{1}+\mathcal{V}_{2}+\mathcal{V}_{3}+ \mathcal{V}_{4}+ \mathcal{V}_{5}-\mathcal{V}\bigl(S(0), I(0), R(0), C(0)\bigr), \end{aligned} $$

where \((S,I,R,C)\in (\frac{1}{n},n)\times (\frac{1}{n},n)\times ( \frac{1}{n},n)\times (\frac{1}{n},n)\) and \(n>1\) is a sufficiently large integer, \(\mathcal{V}_{1}=- \ln S - c_{1} \ln I-c_{2} \ln R-c_{3} \ln C+\xi \int _{t}^{t+\tau }I(s-\tau )\,ds\), \(\mathcal{V}_{2}=-\ln S+\xi \int _{t}^{t+\tau }I(s-\tau )\,ds\), \(\mathcal{V}_{3}=-\ln R\), \(\mathcal{V}_{4}=-\ln C\), and \(\mathcal{V}_{5}=\frac{1}{\rho +1}(S+I+R+C)^{\rho +1}\). \(\rho >1\) is a constant satisfying

$$ \eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}\bigr)>0, $$

and \(Q>0\) is a sufficiently large value satisfying the condition

$$ -Q\mu +w\leq -2, $$

where \(\mu = \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\alpha }\hat{\gamma }\hat{\beta }}-( \eta +\frac{\nu _{1}^{2}}{2})>0\),

$$ \begin{aligned} w={}&\sup_{(S, I, R, C) \in \mathbb{R}^{4}_{+}} \biggl\{ - \frac{1}{4} \biggl[\eta - \frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} \\ &{}+3\eta +\gamma + \beta +2\xi I+A+ \frac{\nu _{1}^{2}}{2} +\frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \biggr\} ,\end{aligned} $$


$$\begin{aligned} \begin{aligned}[b] A&=\sup_{(S, I, R, C) \in \mathbb{R}_{+}^{4}} \biggl\{ \eta (S+I+R+C)^{ \rho }- \frac{1}{2} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr)\biggr] (S+I+R+C)^{\rho +1} \biggr\} \\&< \infty .\end{aligned} \end{aligned}$$

Applying Itô’s formula to \(\mathcal{V}_{1}\), we have

$$ \begin{aligned} \mathcal{L}\mathcal{V}_{1}&= -\frac{\eta }{S}+\eta +\xi I- \frac{\beta C}{S}-\frac{c_{1}\xi SI(t-\tau )}{I} \\ &\quad {}-c_{1} \sigma \xi C+c_{1}( \eta +\alpha )-\frac{c_{2}(1-\sigma )\xi C I}{R}- \frac{c_{2} \alpha I}{R}+c_{2}(\eta +\gamma ) \\ &\quad {} -\frac{c_{3}\gamma R}{C} +c_{3} \xi I+c_{3}(\eta + \beta )+ \frac{\nu _{1}^{2}}{2}+\frac{c_{1}\nu _{2}^{2}}{2}+ \frac{c_{2}\nu _{3}^{2}}{2}+ \frac{c_{3}\nu _{4}^{2}}{2} \\ &\leq -4 \sqrt[4]{\eta \gamma \xi ^{2}(1-\sigma )c_{1}c_{2}c_{3}}+ \eta +\frac{\nu _{1}^{2}}{2}+c_{1}\biggl(\eta +\alpha + \frac{\nu _{2}^{2}}{2} \biggr)+c_{2}\biggl(\eta +\gamma +\frac{\nu _{3}^{2}}{2} \biggr) \\ &\quad {}+c_{3}\biggl( \eta +\beta +\frac{\nu _{4}^{2}}{2}\biggr)+\xi (1+c_{3}) I \\ &\leq - \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\alpha }\hat{\gamma }\hat{\beta }}+ \eta +\frac{\nu _{1}^{2}}{2}+\xi (1+c_{3}) I \\ &=-\mu +\xi (1+c_{3})I. \end{aligned} $$

Similarly, we can get

$$\begin{aligned}& \mathcal{L}\mathcal{V}_{2} = -\frac{\eta }{S} + \eta +\xi I - \frac{\beta C}{S} +\frac{\nu _{1}^{2}}{2}, \end{aligned}$$
$$\begin{aligned}& \mathcal{L}\mathcal{V}_{3}= -\frac{(1- \sigma )\xi CI}{R}- \frac{\alpha I}{R}+\eta +\gamma +\frac{\nu _{3}^{2}}{2}, \end{aligned}$$
$$\begin{aligned}& \mathcal{L}\mathcal{V}_{4} = -\frac{\gamma R}{C}+ \xi I + \eta + \beta + \frac{\nu _{4}^{2}}{2}, \end{aligned}$$
$$\begin{aligned}& \mathcal{L} \mathcal{V}_{5}=(S+I+R+C)^{\rho } \bigl[\eta - \eta (S+I+R+C)\bigr]+ \frac{\rho }{2}(S+I+R+C)^{\rho -1} \\& \hphantom{\mathcal{L} \mathcal{V}_{5}} \quad {} \times \bigl[\nu _{1}^{2} S^{2}+ \nu _{2}^{2} I^{2} + \nu ^{2}_{3} R^{2} + \nu ^{2}_{4} C^{2}\bigr] \\& \hphantom{\mathcal{L} \mathcal{V}_{5}}\leq (S+I+R+C)^{\rho }\bigl[\eta -\eta (S+I+R+C)\bigr]+ \frac{\rho }{2}(S+I+R+C)^{ \rho +1}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \\& \hphantom{\mathcal{L} \mathcal{V}_{5}}\leq \eta (S+I+R+C)^{\rho }- (S+I+R+C)^{\rho +1}\biggl[\eta - \frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr)\biggr] \\& \hphantom{\mathcal{L} \mathcal{V}_{5}}\leq A - \frac{1}{2} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr](S+I+R+C)^{\rho +1} \\& \hphantom{\mathcal{L} \mathcal{V}_{5}}\leq A - \frac{1}{2} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr)\biggr] \bigl(S^{\rho +1}+I^{\rho +1}+R^{ \rho +1}+C^{\rho +1}\bigr), \end{aligned}$$

where A is defined by (16). From equations (17)–(21), we have

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq -Q\mu +Q \xi (1+c_{3})I - \frac{1}{2} \biggl[\eta -\frac{\rho }{2} \bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \bigl(S^{\rho +1}+I^{\rho +1}+R^{ \rho +1}+C^{\rho +1} \bigr) \\ &\quad {}-\frac{\eta }{S} + 3\eta -\frac{\beta C}{S} +\frac{\nu _{1}^{2}}{2} - \frac{\alpha I}{R}+ \gamma +\frac{\nu _{3}^{2}}{2}-\frac{\gamma R}{C}+ 2 \xi I +A +\beta + \frac{\nu _{4}^{2}}{2} \\ &\leq -Q\mu +Q\xi (1+c_{3})I - \frac{1}{4} \biggl[\eta - \frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr)\biggr] \bigl(S^{\rho +1}+I^{ \rho +1}+R^{\rho +1}+C^{\rho +1} \bigr) \\ &\quad {} -\frac{\eta }{S} -\frac{1}{4}\biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr]I^{\rho +1}+ 3\eta - \frac{\beta C}{S} +\frac{\nu _{1}^{2}}{2} - \frac{\alpha I}{R}+\gamma + \frac{\nu _{3}^{2}}{2}-\frac{\gamma R}{C} \\ &\quad{} + 2\xi I +A + \beta + \frac{\nu _{4}^{2}}{2}. \end{aligned}$$

For \(\epsilon >0\), define a bounded closed set

$$ \mathcal{D}= \biggl\{ (S, I, R, C) \in \mathbb{R}_{+}^{4}: \epsilon \leq S \leq \frac{1}{\epsilon }, \epsilon \leq I \leq \frac{1}{\epsilon }, \epsilon ^{2} \leq R \leq \frac{1}{\epsilon ^{2}}, \epsilon ^{3} \leq C \leq \frac{1}{\epsilon ^{3}} \biggr\} . $$

In the set \(\mathbb{R}_{+}^{4} \setminus \mathcal{D}\), let us choose ϵ satisfying the following conditions:

$$\begin{aligned}& -\frac{\eta }{\epsilon }+ H \leq -1, \end{aligned}$$
$$\begin{aligned}& -Q\mu +Q\xi (1+c_{3})\epsilon +w\leq -1, \end{aligned}$$
$$\begin{aligned}& -\frac{\alpha }{\epsilon }+H \leq -1, \end{aligned}$$
$$\begin{aligned}& -\frac{\gamma }{\epsilon }+H \leq -1, \end{aligned}$$
$$\begin{aligned}& - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \frac{1}{\epsilon ^{\rho +1}}+H \leq -1, \end{aligned}$$
$$\begin{aligned}& - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \frac{1}{\epsilon ^{2(\rho +1)}}+H \leq -1, \end{aligned}$$
$$\begin{aligned}& - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \frac{1}{\epsilon ^{3(\rho +1)}}+H \leq -1, \end{aligned}$$


$$\begin{aligned} H ={}&\sup_{(S, I, R, C) \in \mathbb{R}^{4}_{+}} \biggl\{ Q(c_{3}+1) \xi I - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} \\ &{}+3\eta + \gamma +\beta +2\xi I+A+\frac{\nu _{1}^{2}}{2} + \frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \biggr\} . \end{aligned}$$

We need to show that \(\mathcal{L}\widetilde{V} \leq -1\) for any \((S, I, R, C) \in \mathbb{R}^{4}_{+} \setminus \mathcal{D}\), and \(\mathbb{R}^{4}_{+} \setminus \mathcal{D}=\bigcup_{i=1}^{8} \mathcal{D}_{i}\), where

$$\begin{aligned}& \mathcal{D}_{1} =\bigl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; 0< S < \epsilon \bigr\} , \\& \mathcal{D}_{2} =\bigl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; 0< I < \epsilon \bigr\} , \\& \mathcal{D}_{3} =\bigl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; 0< R < \epsilon ^{2}, I \geq \epsilon \bigr\} , \\& \mathcal{D}_{4} =\bigl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; 0< C < \epsilon ^{3}, R \geq \epsilon ^{2} \bigr\} , \\& \mathcal{D}_{5} =\biggl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; S> \frac{1}{\epsilon } \biggr\} , \\& \mathcal{D}_{6} =\biggl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; I> \frac{1}{\epsilon } \biggr\} , \\& \mathcal{D}_{7} =\biggl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; R> \frac{1}{\epsilon ^{2}} \biggr\} , \\& \mathcal{D}_{8} =\biggl\{ (S, I, R, C) \in \mathbb{R}^{4}_{+}; C> \frac{1}{\epsilon ^{3}} \biggr\} . \end{aligned}$$

Case 1. For any \((S, I, R, C) \in \mathcal{D}_{1}\), we obtain

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq -\frac{\eta }{S}+Q(c_{3}+1) \xi I - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta + \gamma +\beta +2\xi I+A \\ &\quad {} +\frac{\nu _{1}^{2}}{2} +\frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq -\frac{\eta }{S}+ H \\ &\leq -\frac{\eta }{\epsilon }+ H \leq -1, \end{aligned}$$

which is obtained from (22). Therefore, \(\mathcal{L}\widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{1}\).

Case 2. For any \((S, I, R, C) \in \mathcal{D}_{2}\), we have

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq -Q\mu +Q\xi (1+c_{3})I - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta +\gamma + \beta +2\xi I \\ &\quad {} +A+\frac{\nu _{1}^{2}}{2} +\frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq -Q\mu +Q\xi (1+c_{3})I+w \\ &\leq -Q\mu +Q\xi (1+c_{3})\epsilon +w < -1, \end{aligned}$$

which follows from (23) and (14). Thus, \(\mathcal{L}\widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{2}\).

Case 3. For any \((S, I, R, C) \in \mathcal{D}_{3}\), we can get

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq -\frac{\alpha I}{R}+Q(c_{3}+1) \xi I - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta + \gamma +\beta +2\xi I+A \\ &\quad {} +\frac{\nu _{1}^{2}}{2} +\frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq -\frac{\alpha \epsilon }{\epsilon ^{2}}+H \leq -1, \end{aligned}$$

which follows from (24). Consequently, \(\mathcal{L}\widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{3}\).

Case 4. For any \((S, I, R, C) \in \mathcal{D}_{4}\), it yields

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq -\frac{\gamma R}{C}+Q(c_{3}+1) \xi I - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta + \gamma +\beta +2\xi I+A \\ &\quad {} +\frac{\nu _{1}^{2}}{2} +\frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq -\frac{\gamma \epsilon ^{2}}{\epsilon ^{3}}+H \leq -1, \end{aligned}$$

which is obtained from (25). Thus, \(\mathcal{L} \widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{4}\).

Case 5. If \((S, I, R, C) \in \mathcal{D}_{5}\), we have

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq - \frac{1}{4} \biggl[\eta - \frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] S^{\rho +1} +Q(c_{3}+1) \xi I \\ &\quad {}- \frac{1}{4} \biggl[ \eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta \\ &\quad {} +\gamma +\beta +2\xi I+A+\frac{\nu _{1}^{2}}{2} + \frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \frac{1}{\epsilon ^{\rho +1}}+H \leq -1, \end{aligned}$$

which is obtained from (26). Then we can obtain \(\mathcal{L}\widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{5}\).

Case 6. If \((S, I, R, C) \in \mathcal{D}_{6}\), we get

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq - \frac{1}{4} \biggl[\eta - \frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1}+Q(c_{3}+1) \xi I \\ &\quad {}- \frac{1}{4} \biggl[ \eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta \\ &\quad {} +\gamma +\beta +2\xi I+A+\frac{\nu _{1}^{2}}{2} + \frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \frac{1}{\epsilon ^{\rho +1}}+H \leq -1, \end{aligned}$$

which is obtained from (26). Hence, \(\mathcal{L} \widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{6}\).

Case 7. If \((S, I, R, C) \in \mathcal{D}_{7}\), it yields

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq - \frac{1}{4} \biggl[\eta - \frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] R^{\rho +1}+Q(c_{3}+1) \xi I \\ &\quad {}- \frac{1}{4} \biggl[ \eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta \\ &\quad {} +\gamma +\beta +2\xi I+A+\frac{\nu _{1}^{2}}{2} + \frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \frac{1}{\epsilon ^{2\rho +2}}+H \leq -1, \end{aligned}$$

which is obtained from (27). Hence, \(\mathcal{L} \widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{7}\).

Case 8. If \((S, I, R, C) \in \mathcal{D}_{8}\), we can see that

$$\begin{aligned} \mathcal{L}\widetilde{V} &\leq - \frac{1}{4} \biggl[\eta - \frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] C^{\rho +1}+Q(c_{3}+1) \xi I \\ &\quad {}- \frac{1}{4} \biggl[ \eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] I^{\rho +1} +3\eta \\ &\quad {} +\gamma +\beta +2\xi I+A+\frac{\nu _{1}^{2}}{2} + \frac{\nu _{3}^{2}}{2}+ \frac{\nu _{4}^{2}}{2} \\ &\leq - \frac{1}{4} \biggl[\eta -\frac{\rho }{2}\bigl(\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu ^{2}_{3} \vee \nu ^{2}_{4} \bigr) \biggr] \frac{1}{\epsilon ^{3\rho +3}}+H \leq -1, \end{aligned}$$

which is obtained from (28). Therefore, \(\mathcal{L}\widetilde{V}\leq -1\) for any \((S,I,R,C)\in D_{8}\).

Clearly, condition \((\mathit{ii})\) of Lemma 1 holds. Therefore, we conclude that system (2) identifies a unique stationary distribution \(\pi (\cdot )\).


In order to show the extinction of the disease, we go through the following lemmas.

Lemma 2


Let \(M=\{M_{t}\}_{t\geq 0}\)be a real-valued continuous local martingale vanishing at \(t=0\). Then

$$ \lim_{t \rightarrow \infty } \langle M,M \rangle _{t} =\infty \quad \textit{a.s.} \quad \Rightarrow \quad \lim_{t \rightarrow \infty } \frac{M_{t}}{\langle M,M \rangle _{t}}=0\quad \textit{a.s.}, $$

and also

$$ \lim \sup_{t\rightarrow \infty } \frac{\langle M,M \rangle _{t}}{t}< \infty \quad \textit{a.s.} \quad \Rightarrow \quad \lim_{t\rightarrow \infty } \frac{M_{t}}{t}=0 \quad \textit{a.s.}, $$

where \(\langle M,M \rangle _{t}\)denotes the quadratic variation of M.

Lemma 3

(see Lemmas 2.1 and 2.2 in [39])

Let \((S(t), I(t), R(t), C(t))\)be the solution of (2) with any \((S(0), I(0), R(0), C(0)) \in \mathbb{R}_{+}^{4}\), then

$$ \lim_{t \rightarrow \infty } \frac{S(t)}{t}=0, \quad\quad \lim _{t \rightarrow \infty } \frac{I(t)}{t}=0, \quad\quad \lim _{t \rightarrow \infty } \frac{R(t)}{t}=0, \quad\quad \lim _{t \rightarrow \infty } \frac{C(t)}{t}=0, \quad \textit{a.s.} $$

Furthermore, if \(\eta > \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}\), then

$$\begin{aligned}& \lim_{t \rightarrow \infty } \frac{\int _{0}^{t}S(s)\,dW_{1}(s)}{t}=0, \quad \quad \lim _{t \rightarrow \infty } \frac{\int _{0}^{t}I(s)\,dW_{2}(s)}{t}=0, \quad \quad \lim _{t \rightarrow \infty } \frac{\int _{0}^{t}R(s)\,dW_{3}(s)}{t}=0, \\& \lim_{t \rightarrow \infty } \frac{\int _{0}^{t}C(s)\,dW_{4}(s)}{t}=0, \quad \textit{a.s.} \end{aligned}$$

Theorem 3

If \(\mathcal{R}_{0}^{s}<1\)and \(\eta > \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}\), then the solution of (2) satisfies the following: \(\lim_{t \rightarrow \infty } \sup \frac{1}{t}\ln ( \alpha (I(t)+C(t))+(\eta +\alpha ) R(t)) \leq \xi - \frac{1}{2(\alpha )^{2}} \{ \alpha ^{2} \frac{\nu ^{2}_{2}}{2} \wedge (\eta (\eta +\alpha +\gamma )+ (\eta +\alpha )^{2} \frac{\nu _{3}^{2}}{2}) \wedge \alpha ^{2}(\eta +\beta + \frac{\nu _{4}^{2}}{2}) \} <0\)and \(\lim_{t \rightarrow \infty } \langle S \rangle =1\)a.s.

Proof 3

Define \(U(t)=\alpha (I(t)+C(t))+(\eta +\alpha ) R(t)\), taking Ito’s formula, we can get

$$\begin{aligned}& d \ln U(t) \\& \quad = \biggl\{ \frac{1}{\alpha (I+C)+(\eta +\alpha ) R} \bigl[ \alpha \xi S{I(t-\tau )}- \alpha (\eta + \beta )C-\bigl(\eta ^{2}+\eta \alpha + \eta \gamma \bigr)R \bigr] \\& \quad \quad {} - \frac{ [\alpha ^{2} \nu ^{2}_{2}I^{2}+(\eta +\alpha )^{2} \nu ^{2}_{3} R^{2}+\alpha ^{2} \nu ^{2}_{4} C^{2} ]}{2(\alpha (I+C)+(\eta +\alpha ) R)^{2}} \biggr\} \,dt + \frac{\alpha \nu _{2} I}{\alpha (I+C)+(\eta +\alpha ) R} \,dW_{2}(t) \\& \quad \quad {} + \frac{(\eta +\alpha ) \nu _{3} R}{\alpha (I+C)+(\eta +\alpha ) R}\,dW_{3}(t)+ \frac{\alpha \nu _{4} C}{\alpha (I+C)+(\eta +\alpha ) R} \,dW_{4}(t) \\& \quad \leq \xi S \,dt- \frac{1}{(\alpha (I+C)+(\eta +\alpha ) R)^{2}} \biggl\{ \alpha ^{2} \frac{\nu ^{2}_{2}}{2}I^{2}+ \alpha ^{2}\biggl(\eta + \beta + \frac{\nu _{4}^{2}}{2}\biggr) C^{2} +\biggl(\eta (\eta +\alpha +\gamma ) \\& \quad \quad {} +(\eta +\alpha )^{2} \frac{\nu _{3}^{2}}{2} \biggr)R^{2} \biggr\} \,dt + \frac{\alpha \nu _{2} I}{\alpha (I+C)+(\eta +\alpha ) R}\,dW_{2}(t) \\& \quad \quad {} + \frac{(\eta +\alpha ) \nu _{3} R}{\alpha (I+C)+(\eta +\alpha ) R}\,dW_{3}(t)+ \frac{\alpha \nu _{4} C}{\alpha (I+C)+(\eta +\alpha ) R} \,dW_{4}(t) \\& \quad \leq \xi S \,dt- \frac{1}{2(\alpha )^{2}} \biggl\{ \alpha ^{2} \frac{\nu ^{2}_{2}}{2}\wedge \biggl(\eta (\eta +\alpha +\gamma )+ (\eta + \alpha )^{2} \frac{\nu _{3}^{2}}{2}\biggr) \wedge \alpha ^{2}\biggl(\eta +\beta + \frac{\nu _{4}^{2}}{2}\biggr) \biggr\} \,dt \\& \quad \quad {} + \frac{\alpha \nu _{2} I}{\alpha (I+C)+(\eta +\alpha ) R}\,dW_{2}(t)+ \frac{(\eta +\alpha ) \nu _{3} R}{\alpha (I+C)+(\eta +\alpha ) R} \,dW_{3}(t) \\& \quad \quad {} + \frac{\alpha \nu _{4} C}{\alpha (I+C)+(\eta +\alpha ) R}\,dW_{4}(t). \end{aligned}$$

From model (2), we have

$$\begin{aligned} d\bigl(S(t)+I(t)+R(t)+C(t)\bigr)&= \bigl[\eta -\eta \bigl(S(t)+I(t)+R(t)+C(t) \bigr) \bigr]\,dt + \nu _{1} S(t) \,dW_{1}(t) \\ & \quad {} + \nu _{2} I(t) \,dW_{2}(t) + \nu _{3} R(t) \,dW_{3}(t)+\nu _{4} C(t)\,dW_{4}(t). \end{aligned}$$

Taking integration of (30) from 0 to t, we obtain

$$ \bigl\langle S(t)+I(t)+R(t)+C(t) \bigr\rangle =1+\psi _{1}(t), $$


$$ \begin{aligned} \psi _{1}(t)&=\frac{1}{\eta } \biggl[ \frac{1}{t}\bigl(S(0)+I(0)+R(0)+C(0)\bigr) \\ &\quad {}- \frac{1}{t} \bigl(S(t)+I(t)+R(t)+C(t)\bigr) + \frac{\nu _{1}\int _{0}^{t}S(s)\,dW_{1}(s)}{t} \\ &\quad {} + \frac{\nu _{2}\int _{0}^{t}I(s)\,dW_{2}(s)}{t} + \frac{\nu _{3}\int _{0}^{t}R(s)\,dW_{3}(s)}{t}+ \frac{\nu _{4}\int _{0}^{t}C(s)\,dW_{4}(s)}{t} \biggr]. \end{aligned} $$

By Lemmas 2 and 3, we can easily obtain that

$$ \lim_{t\rightarrow \infty } \psi _{1}(t)=0\quad \text{a.s.} $$

Therefore, by taking the superior limit on both sides of (31), we obtain

$$ \lim_{t \rightarrow \infty } \sup \bigl\langle S(t)+I(t)+R(t)+C(t)\bigr\rangle =1 \quad \text{a.s.} $$

Integrating (29) from 0 to t, we obtain

$$ \begin{aligned} \frac{\ln U(t)}{t}\leq {}&\xi -\frac{1}{2(\alpha )^{2}} \biggl\{ \alpha ^{2} \frac{\nu ^{2}_{2}}{2}\wedge \biggl(\eta (\eta +\alpha +\gamma )+ ( \eta + \alpha )^{2} \frac{\nu _{3}^{2}}{2}\biggr) \wedge \alpha ^{2}\biggl(\eta +\beta + \frac{\nu _{4}^{2}}{2}\biggr) \biggr\} \\ &{}+\psi _{2}(t), \end{aligned} $$


$$\begin{aligned} \psi _{2}(t)&=\frac{\ln U(0)}{t}+ \frac{\alpha \nu _{2}}{t} \int _{0}^{t} \biggl( \frac{ I(s)}{\alpha (I(s)+C(s))+(\eta +\alpha ) R(s)} \,dW_{2}(s) \biggr) \\ &\quad {} +\frac{(\eta +\alpha ) \nu _{3}}{t} \int _{0}^{t} \biggl( \frac{ R(s)}{\alpha (I(s)+C(s))+(\eta +\alpha ) R(s)} \,dW_{3}(s) \biggr) \\ & \quad {} +\frac{\alpha \nu _{4}}{t} \int _{0}^{t} \biggl( \frac{ C(s)}{\alpha (I(s)+C(s))+(\eta +\alpha ) R(s)} \,dW_{4}(s) \biggr). \end{aligned}$$

In the same manner, by Lemmas 2 and 3, we have

$$ \lim_{t\rightarrow \infty } \psi _{2}(t)=0\quad \text{a.s.} $$

Since \(\mathcal{R}_{0}^{s}<1\), therefore, by taking the superior limit of both sides of (34), we have

$$ \begin{aligned} & \lim_{t \rightarrow \infty } \sup \frac{\ln U(t)}{t} \\ &\quad \leq \xi - \frac{1}{2(\alpha )^{2}} \biggl\{ \alpha ^{2} \frac{\nu ^{2}_{2}}{2} \wedge \biggl(\eta (\eta +\alpha +\gamma )+ (\eta +\alpha )^{2} \frac{\nu _{3}^{2}}{2}\biggr) \wedge \alpha ^{2}\biggl(\eta +\beta + \frac{\nu _{4}^{2}}{2}\biggr) \biggr\} \\ &\quad < 0, \end{aligned} $$

which implies that \(\lim_{t \rightarrow \infty }I(t)=0\), \(\lim_{t \rightarrow \infty }R(t)=0\), \(\lim_{t \rightarrow \infty }C(t)=0\) a.s., which confirms that the disease I can die out with probability one.

It is easy, by using (33) and (35), to show that \(\lim_{t \rightarrow \infty } \langle S\rangle =1\) a.s.

Numerical simulations and discussions

Numerical simulations are given to validate our theoretical results through Euler–Maruyama method for SDDEs reported in [40, 41] to numerically solve SDDEs (2).

The discretization transformation takes the form

$$\begin{aligned} \begin{aligned} &S_{j+1}= S_{j}+ \bigl[\eta (1-S_{j})-\xi S_{j}I_{j-m}+\beta C_{j} \bigr] \Delta t+\nu _{1} S_{j}\sqrt{\Delta t}\zeta _{1, j}, \\ &I_{j+1}=I_{j}+\bigl[\xi S_{j}I_{j-m}+ \sigma \xi C_{j}I_{j}-(\eta + \alpha )I_{j}\bigr] \Delta t+ \nu _{2} I_{j} \sqrt{\Delta t}\zeta _{2, j}, \\ &R_{j+1}= R_{j}+\bigl[(1- \sigma )\xi C_{j}I_{j}+ \alpha I_{j}-(\eta + \gamma )R_{j}\bigr]\Delta t +\nu _{3} R_{j}\sqrt{\Delta t}\zeta _{3, j}, \\ &C_{j+1}= C_{j}+\bigl[\gamma R_{j}-\xi C_{j}I_{j}-(\eta +\beta )C_{j}\bigr] \Delta t +\nu _{4} C_{j}\sqrt{\Delta t}\zeta _{4, j}. \end{aligned} \end{aligned}$$

The independent Gaussian random variables denoted as \(\zeta _{i, j}\) (\(i=1, 2, 3, 4\)), which follow the distribution \(N(0, 1)\), the time-delay is defined as \(\tau =m\Delta t\), m is an integer, and the step size Δt. Let \(\nu _{i}>0\), (\(i=1, 2, 3, 4\)) be the white noise values.

Example 1

Consider model (2) with white noise values \(\nu _{1}=0.1\), \(\nu _{2}=0.09\), \(\nu _{3}=0.09\), \(\nu _{4}=0.07\) and parameter values \(\eta =0.09\), \(\xi =1.3\), \(\beta =0.05\), \(\sigma =0.9\), \(\gamma =0.1\), \(\alpha =0.36\), \(\tau =1.2\). Simple calculation leads to \(\mathcal{R}^{s}_{0}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\eta }\hat{\alpha }\hat{\gamma }\hat{\beta }}=1.3>1\) and \(\eta - \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}=0.087>0\). Therefore, the conditions of Theorem 2 hold. Based on Theorem 2, there is a unique ergodic stationary distribution \(\pi (\cdot )\) of model (2). Thus, the disease I is persistent; see Fig. 2.

Figure 2

Shows numerical simulations of stochastic model (2) when \({\mathcal{R}}_{0}^{s}=1.3>1\), with \(\eta =0.09\), \(\xi =1.3\), \(\beta =0.05\), \(\sigma =0.9\), \(\alpha =0.36\), \(\gamma =0.1\); \(\tau =1\) and white noises \(\nu _{1}=0.1\), \(\nu _{2}=0.09\), \(\nu _{3}=0.09\), \(\nu _{4}=0.07\). The model has a unique ergodic stationary distribution and the infection is persistent

Example 2

Given model (2) with parameter values \(\eta =0.0005\); \(\xi =0.6\); \(\beta =0.01\); \(\sigma =0.12\); \(\alpha =0.3\); \(\gamma =0.02\), \(\tau =1.4\) and white noises \(\nu _{1}=0.02\), \(\nu _{2}=0.02\), \(\nu _{3}=0.01\), \(\nu _{4}=0.2\). We obtain \(\mathcal{R}^{s}_{0}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\eta }\hat{\alpha }\hat{\gamma }\hat{\beta }}=0.38<1\) and \(\eta - \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}=-0.0195<0\). In this case, the conditions of Theorem 2 are not satisfied. From Fig. 3, we can clearly find that the disease goes to extinction. In Fig. 4 time-delay is increased to \(\tau =2.5\), with white noises \(\nu _{1}=0.01\), \(\nu _{2}=0.2\), \(\nu _{3}=0.02\), \(\nu _{4}=0.03\), other parameter values are the same as in Fig. 3. Therefore \(\mathcal{R}_{0}^{s}<1\) and \(\eta - \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}=-0.0445<0\). The conditions of Theorem 2 are not satisfied. Figure 4 shows a periodic outbreak due to the time-delay τ. However, the infection dies out with time with bigger white noise.

Figure 3

Time domain behaviors of solutions of SDDEs model (2) (right) and the corresponding deterministic model (1) (left) when \({\mathcal{R}}_{0}^{s}=0.38<1\), with \(\eta =0.0005\), \(\xi =0.6\), \(\beta =0.01\), \(\sigma =0.12\), \(\alpha =0.3\), \(\gamma =0.02\); \(\tau =1.4\) and white noises \(\nu _{1}=\nu _{2}=0.02\), \(\nu _{3}=0.01\), \(\nu _{4}=0.02\). The infection dies out with probability one

Figure 4

Time domain behaviors of SDDEs model (2) (right) and corresponding deterministic model (1) (left) when \({\mathcal{R}}_{0}^{s}=0.38<1\), with \(\eta =0.0005\), \(\xi =0.6\), \(\beta =0.01\), \(\sigma =0.12\), \(\alpha =0.3\), \(\gamma =0.02\); \(\tau =2.5\) and white noises \(\nu _{1}=0.02\), \(\nu _{2}=0.2\), \(\nu _{3}=0.02\), \(\nu _{4}=0.2\). The figure shows a periodic outbreak due to the time-delay τ

Example 3

To further explain the impact time-delay and white noises on system (2), we choose \(\tau =2.5\) and parameter values \(\eta =0.0005\); \(\xi =0.6\); \(\beta =0.01\); \(\sigma =0.12\); \(\alpha =0.3\); \(\gamma =0.02\), and white noises \(\nu _{1}=0.2\), \(\nu _{2}=0.2\), \(\nu _{3}=0.1\), \(\nu _{4}=0.3\), such that \(\mathcal{R}^{s}_{0}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\eta }\hat{\alpha }\hat{\gamma }\hat{\beta }}=0.38<1\) and \(\eta - \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}=-0.045<0\). Thus, the conditions of Theorem 2 are not satisfied. Figure 5 shows a periodic outbreak due to the time-delay τ when the white noise increased the periodicity of the outbreak decreased. The infection dies out with time as white noise increases.

Figure 5

Simulations of stochastic model (2) (right) and the corresponding deterministic model (1) (left) when \({\mathcal{R}}_{0}^{s}=0.38<1\), with \(\eta =0.0005\), \(\xi =0.6\), \(\beta =0.01\), \(\sigma =0.12\), \(\alpha =0.3\), \(\gamma =0.02\); \(\tau =2.5\) and white noises \(\nu _{1}=0.2\), \(\nu _{2}=0.2\), \(\nu _{3}=0.1\), \(\nu _{4}=0.2\). The deterministic model shows a periodic outbreak due to the time-delay τ. The infection dies out with time when white noise is large

Example 4

In order to show the impact of random perturbation, with \(\tau =1\), we increase the white noise values \(\nu _{1}=0.13\), \(\nu _{2}=0.54\), \(\nu _{3}=0.26\), \(\nu _{4}=0.75\) with parameter values \(\eta =0.02\); \(\xi =0.5\); \(\beta =0.1\); \(\sigma =0.2\); \(\alpha =0.26\); \(\gamma =1\). Thus, \(\mathcal{R}^{s}_{0}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\eta }\hat{\alpha }\hat{\gamma }\hat{\beta }}=0.75<1<1.78= \frac{\xi }{\alpha +\eta }=\mathcal{R}_{0}\), and \(\eta - \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}=0.0115>0\). Therefore, the conditions of Theorem 3 hold, and disease dies out exponentially with probability one. However, the disease persists with deterministic model; see Fig. 6.

Figure 6

Time domain behaviors of SDDEs model (2) (right) and corresponding deterministic model (1) (left), where \(\tau =1\), when \({\mathcal{R}}_{0}=1.78>1\), the infection persists in the deterministic model; when \({\mathcal{R}}_{0}^{s}=0.75<1\), the infection dies out in the stochastic model. With parameter values \(\eta =0.02\), \(\xi =0.5\), \(\beta =0.1\), \(\sigma =0.2\), \(\alpha =0.26\), \(\gamma =1\) and white noises \(\nu _{1}=0.13\), \(\nu _{2}=0.54\), \(\nu _{3}=0.26\), \(\nu _{4}=0.75\)

Example 5

Consider the same parameter values of Example 4, but with time-delay \(\tau =0\). Thus, according to Theorem 3, the disease dies out exponentially with probability one; see Fig. 7. Therefore, the smaller values of white noise ensure the existence of unique stationary distribution, which gives the persistence of the disease; while larger values of white noise can lead to disease extinction.

Figure 7

Time response of solutions for model (2) (right) and corresponding deterministic model (1) (left), when \({\mathcal{R}}_{0}=1.78>1\), the infection persists in the deterministic model; when \({\mathcal{R}}_{0}^{s}=0.75<1\), the infection dies out in the stochastic model. With parameter values \(\eta =0.02\), \(\xi =0.5\), \(\beta =0.1\), \(\sigma =0.2\), \(\alpha =0.26\), \(\gamma =1\) and white noises \(\nu _{1}=0.13\), \(\nu _{2}=0.54\), \(\nu _{3}=0.26\), \(\nu _{4}=0.75\)

Remark 1

Given the deterministic SIRC model (1), if the basic reproduction number \(\mathcal{R}_{0} =\frac{\xi }{\alpha +\eta }<1 \), then the disease-free equilibrium point is globally asymptotically stable; whereas if \(\mathcal{R}_{0} > 1\), the unique endemic equilibrium point is globally asymptotically stable. Repeated outbreaks of the infection can occur due to the time-delay in the transmission terms. In our stochastic SIRC model (2), if \(\mathcal{R}_{0}^{s}= \frac{\eta \gamma \xi ^{2}(1-\sigma )}{\hat{\eta }\hat{\alpha }\hat{\gamma }\hat{\beta }}<1< \mathcal{R}_{0}\) and \(\eta > \frac{\nu _{1}^{2} \vee \nu _{2}^{2} \vee \nu _{3}^{2} \vee \nu _{4}^{2}}{2}\), the stochastic model (2) has disease extinction with probability one, and for \(\mathcal{R}_{0}^{s}>1\), the model has a unique ergodic stationary distribution. See Figs. 5, 6, and 7.


In this work, we provided a stochastic SIRC epidemic model with time-delay for the new strain coronavirus COVID-19. The stochastic components, due to environmental variability, are incorporated in the model as Gaussian white noise. We established some sufficient conditions for persistence and extinction in the mean of the disease. The model has a unique stationary distribution which is ergodic if the intensity of white noise is small. Introduction of noise in the deterministic SIRC model modifies the basic reproductive number \({\mathcal{R}}_{0}\) giving rise to a new threshold quantity \({\mathcal{R}}_{0}^{s}\). It has been proved that the disease dies out if \({\mathcal{R}}_{0}^{s} < 1<{\mathcal{R}}_{0}\). On the other hand, if \({\mathcal{R}}_{0}^{s}>1\) and \({\mathcal{R}}_{0}>1\), the disease persists with both models, but with different behaviors. In other words, extinction of the infection possibly occurs when \({\mathcal{R}}_{0}^{s}<1<{\mathcal{R}}_{0}\) and the intensity of white noise is large. This would not happen in the deterministic models. The potential of using stochastic SIRC model for COVID-19 is to consider the environmental fluctuation that all affects the spread of the virus. The periodicity of outbreaks is possible due to the presence of time-delay (memory) in the transmission terms.

The authors believe that the stochastic SIRC model is an attempt to understand epidemiological characteristics of COVID-19. The model provides new insights into epidemiological situations when the environmental noise (perturbations) and cross-immunity are considered in the COVID-19 epidemic models. The combination of white noise and time-delay, in the epidemic model, has a considerable impact on the persistence and extinction of the infection and enriches the dynamics of the model. This work can be extended to include control variables for vaccination, treatment, and/or quarantine actions. A more sophisticated model is also required to investigate the dynamics of COVID-19 with immune system in cells level [42]. Fractional derivatives can also be included in the model to consider long-run memory [43, 44].


  1. 1.

    Cross-immunity (or cross-reactivity) is a major evolutionary force that affects pathogen diversity (i.e. it drives viruses and microbes to be as distinct as possible from one another in order to avoid immunity detection, memory recognition, and clearance).


  1. 1.

    Hui, D., et al.: The continuing 2019-ncov epidemic threat of novel coronavirus to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 91, 264–266 (2020)

    Google Scholar 

  2. 2.

    Grifoni, A., Weiskopf, D., et al.: Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489–1501 (2020)

    Google Scholar 

  3. 3.

    World Health Organization: Advice for public. WHO Int. (2020)

  4. 4.

    WHO: Report of the WHO–China joint mission on coronavirus disease 2019 (COVID-19). World Health Organization (2020)

  5. 5.

    Anderson, R., May, R.: Infectious Disease of Humans, Dynamics and Control. Oxford University Press, Oxford (1995)

    Google Scholar 

  6. 6.

    Capasso, V.: Mathematical structure of epidemic systems. In: Lect. Notes in Biomath., vol. 97. Springer, Berlin (1993)

    Google Scholar 

  7. 7.

    Kashkynbayev, A., Koptleuova, D.: Global dynamics of tick-borne diseases. Math. Biosci. Eng. 17(4), 4064–4079 (2020)

    Google Scholar 

  8. 8.

    Issanov, A., Amanbek, Y., Abbay, A., Adambekov, S., Aljofan, M., Kashkynbayev, A., Gaipov, A.: COVID-19 outbreak in Post-Soviet States: modeling the best and worst possible scenarios. Electron. J. Gen. Med. 17(6), em256 (2020)

    Google Scholar 

  9. 9.

    Casagrandi, R., Bolzoni, L., Levin, S., Andreasen, V.: The SIRC model and influenza A. Math. Biosci. 200, 152–169 (2006)

    MathSciNet  MATH  Google Scholar 

  10. 10.

    Rihan, F.A., Baleanu, D., Lakshmanan, S., Rakkiyappan, R.: On fractional SIRC model with Salmonella bacterial infection. Abstr. Appl. Anal. 2014, 136263 (2014)

    MathSciNet  MATH  Google Scholar 

  11. 11.

    Khan, M.A., Atangana, A.: Modeling the dynamics of novel coronavirus (2019-nCov) with fractional derivative. Alex. Eng. J. 59(4), 2379–2389 (2020)

    Google Scholar 

  12. 12.

    Hethcote, H., Zhien, M., Shengbing, L.: Effects of quarantine in six endemic models for infectious diseases. Math. Biosci. 180, 141–160 (2002)

    MathSciNet  MATH  Google Scholar 

  13. 13.

    Lahrouz, A., Settati, A.: Necessary and sufficient condition for extinction and persistence of SIRS system with random perturbation. Appl. Math. Comput. 233, 10–19 (2014)

    MathSciNet  MATH  Google Scholar 

  14. 14.

    Yang, Q., Mao, X.: Extinction and recurrence of multi-group SEIR epidemic models with stochastic perturbations. Nonlinear Anal., Real World Appl. 14, 1434–1456 (2013)

    MathSciNet  MATH  Google Scholar 

  15. 15.

    Liu, Q., Jiang, D., Hayat, T., Alsaedi, A.: Dynamics of a stochastic tuberculosis model with antibiotic resistance. Chaos Solitons Fractals 109, 223–230 (2018)

    MathSciNet  MATH  Google Scholar 

  16. 16.

    Wei, F., Xue, R.: Stability and extinction of SEIR epidemic models with generalized nonlinear incidence. Math. Comput. Simul. 170, 1–15 (2020)

    MathSciNet  Google Scholar 

  17. 17.

    Zhao, X., Zeng, Z.: Stationary distribution and extinction of a stochastic ratio dependent predator prey system with stage structure for the predator. Physica A (2019).

    Article  Google Scholar 

  18. 18.

    Bahar, A., Mao, X.: Stochastic delay Lotka–Volterra model. J. Math. Anal. Appl. 292, 364–380 (2004)

    MathSciNet  MATH  Google Scholar 

  19. 19.

    Mao, X., Sabanis, S., Renshaw, E.: Asymptotic behaviour of the stochastic Lotka–Volterra model. J. Math. Anal. Appl. 287, 141–156 (2003)

    MathSciNet  MATH  Google Scholar 

  20. 20.

    Mao, X., Yuan, C., Zou, J.: Stochastic differential delay equations of population dynamics. J. Math. Anal. Appl. 304, 296–320 (2005)

    MathSciNet  MATH  Google Scholar 

  21. 21.

    Mao, X., Marion, G., Renshaw, E.: Environmental Brownian noise suppresses explosions in population dynamics. Stoch. Process. Appl. 97, 95–110 (2002)

    MathSciNet  MATH  Google Scholar 

  22. 22.

    Yuan, Y., Allen, L.J.S.: Stochastic models for virus and immune system dynamics. Math. Biosci. 234, 84–94 (2011)

    MathSciNet  MATH  Google Scholar 

  23. 23.

    Ji, C.: The stationary distribution of hepatitis B virus with stochastic perturbation. Appl. Math. Lett. 100, 106017 (2020)

    MathSciNet  MATH  Google Scholar 

  24. 24.

    Ji, C., Jiang, D.: Threshold behaviour of a stochastic SIR model. Appl. Math. Model. 38(21–22), 5067–5079 (2014)

    MathSciNet  MATH  Google Scholar 

  25. 25.

    Lakshmi, P., Suresh, M.: Factors influencing the epidemiological characteristics of pandemic COVID 19: a TISM approach. Int. J. Healthc. Manag. 13, 89–98 (2020)

    Google Scholar 

  26. 26.

    Azman, A., Rudolph, K., Cummings, D., Lessler, J.: The incubation period of cholera: a systematic review. J. Infect. 66(5), 432–438 (2013)

    Google Scholar 

  27. 27.

    Lessler, J., Reich, N., Brookmeyer, R., Perl, T., Nelson, K., Cummings, D.: Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect. Dis. 9, 291–300 (2009)

    Google Scholar 

  28. 28.

    World Health Organization, et al.: Are the ebola outbreaks in nigeria and senegal over. (2014)

  29. 29.

    Kahn, J., Walker, B.: Acute human immunodeficiency virus type 1 infection. N. Engl. J. Med. 339(1), 33–39 (1998)

    Google Scholar 

  30. 30.

    Al-Jasser, F., Nouh, R., Youssef, R.: Epidemiology and predictors of survival of MERS–CoV infections in Riyadh Region, 2014–2015. J. Infect. Publ. Health 12(2), 171–177 (2019)

    Google Scholar 

  31. 31.

    Seto, W., Tsang, D., Yung, R., Ching, T., Ng, T., Ho, M., Ho, L., Peiris, J., Advisors of Expert SARS group of Hospital Authority, et al.: Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361(9368), 1519–1520 (2003)

    Google Scholar 

  32. 32.

    Jodar, L., Villanueva, R.J., Arenas, A.J., Gonzalez, G.C.: Nonstandard numerical methods for a mathematical model for influenza disease. Math. Comput. Simul. 79, 622–633 (2008)

    MathSciNet  MATH  Google Scholar 

  33. 33.

    Bocharov, G., Rihan, F.A.: Numerical modelling in biosciences using delay differential equations. J. Comput. Appl. Math. 125, 183–199 (2000)

    MathSciNet  MATH  Google Scholar 

  34. 34.

    Rihan, F.A., Alsakaji, H.J.: Persistence and extinction for stochastic delay differential model of prey predator system with hunting cooperation in predators. Adv. Differ. Equ. 2020(1), 124 (2020)

    MathSciNet  Google Scholar 

  35. 35.

    Buckwar, E.: Introduction to the numerical analysis of stochastic delay differential equations. J. Comput. Appl. Math. 125(1–2), 297–307 (2000)

    MathSciNet  MATH  Google Scholar 

  36. 36.

    Mao, X.: Stochastic Differential Equations and Applications. Elsevier, Amsterdam (2008)

    Google Scholar 

  37. 37.

    Hasminskii, R.Z.: Stochastic Stability of Differential Equations. Springer, Berlin (1980)

    Google Scholar 

  38. 38.

    Liptser, R.S.: A strong law of large numbers for local martingales. Stochastics 3(1–4), 217–228 (1980)

    MathSciNet  MATH  Google Scholar 

  39. 39.

    Zhao, Y., Jiang, D.: The thershold of a stochastic SIS epidemic model with vaccination. Appl. Math. Comput. 243, 718–727 (2014)

    MathSciNet  MATH  Google Scholar 

  40. 40.

    Mao, X.: Stochastic Differential Equations and Their Applications. Horwood, Chichester (1997)

    MATH  Google Scholar 

  41. 41.

    Buckwar, E.: Euler–Maruyama and Milstein approximations for stochastic functional differential equations with distributed memory term. Technical report, Humboldt-Universität zu Berlin, Wirtschaftswissenschaftliche Fakultät (2005)

  42. 42.

    Rihan, F.A., Velmurugan, G.: Dynamics and sensitivity analysis of fractional-order delay differential model for coronavirus infection. Prog. Fract. Differ. Appl. (2020, in press). Accepted on 12 April

  43. 43.

    Atangana, A., AkgulKolade, A., Owolabi, M.: Analysis of fractal fractional differential equations. Alex. Eng. J. 59, 117–1134 (2020)

    Google Scholar 

  44. 44.

    Rihan, F.A., Al-Mdallal, Q., AlSakaji, H.J., Hashish, A.: A fractional-order epidemic model with time-delay and nonlinear incidence rate. Chaos Solitons Fractals 126, 97–105 (2019)

    MathSciNet  Google Scholar 

Download references


The authors thank the reviewers and editor for their constructive comments that improved this manuscript.

Availability of data and materials

Data sharing is not applicable to this paper as no datasets were generated or analyzed during the current study.


This work is generously funded by PhD Program and UPAR Project (G00003440), United Arab Emirates University (UAE).

Author information




All authors contributed equally and significantly in writing this paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to F. A. Rihan.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rihan, F.A., Alsakaji, H.J. & Rajivganthi, C. Stochastic SIRC epidemic model with time-delay for COVID-19. Adv Differ Equ 2020, 502 (2020).

Download citation


  • Brownian motion
  • COVID-19
  • Cross-immunity
  • Extinction
  • Stationary distribution
  • Stochastic SIRC model